Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats

Parathyroid hormone (PTH) is an effective bone anabolic agent, but it must be administered parenterally. An orally active anabolic agent would provide a valuable alternative for treating osteoporosis. NPS 2143 is a novel, selective antagonist (a “calcilytic”) of the parathyroid cell Ca(2+) receptor....

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Invest
Päätekijät:	Gowen, Maxine, Stroup, George B., Dodds, Robert A., James, Ian E., Votta, Bart J., Smith, Brian R., Bhatnagar, Pradip K., Lago, Amparo M., Callahan, James F., DelMar, Eric G., Miller, Michael A., Nemeth, Edward F., Fox, John
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Clinical Investigation 2000
Aiheet:	Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC300853/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10841518/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI9038
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!